Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New UI elements 'Check who can join' and 'Find Contact Information' appear, and the revision tag updated to v3.6.0 (replacing v3.5.5). These changes reflect UI and release updates rather than modifications to study data.
    Difference
    0.5%
    Check dated 2026-06-12T16:44:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the study history and the previous revision v3.5.4 was removed.
    Difference
    0.1%
    Check dated 2026-06-05T15:40:35.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry for v3.5.4 and removes the previous v3.5.3 entry, updating the page's release notes to reflect the latest versioning of the study record.
    Difference
    0.1%
    Check dated 2026-05-15T06:43:42.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.2 to v3.5.3, indicating a backend/site release rather than a modification to the clinical trial’s record history or study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:46.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:53.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Study Design and Study Status entries in the latest history versions; a previous entry dated 2026-03-05 was removed.
    Difference
    0.5%
    Check dated 2026-04-02T15:23:15.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.